The brand effect: how different MRI machines trip up AI
Prostate cancer can vary greatly in how aggressive it is, and knowing this in advance helps doctors decide the best course of treatment. Magnetic resonance imaging (MRI) is often used to detect prostate cancer, but figuring out just how aggressive the cancer is...
Dissemination Event of the ProCAncer-I Project in Vienna
We are delighted to invite you to our session, “ProCAncer-I: An AI Platform Integrating Multiparametric MRI and AI Models”, at the European Congress of Radiology (ECR) 2025. Date: 26 February 2025 Time: 15:00 – 16:00 Location: ECR 2025, Vienna, Austria (conference...
ProCAncer-I at the ECR 2025 in Vienna
ProCAncer-I will organise a Dedicated Session on the project during the European Congress of Radiology 2025 on the 26th of February 2025, at 15.00-16.00, with the title "ProCAncer-I: an AI platform integrating multiparametric MRI and AI models" where we will present...
ProCAncer-I at the Healthcare Business Awards 2024
Harnessing Big Data for the Future of Healthcare: Innovative Solutions with EUCAIM, ProCAncer-I, and European Health Data Spaces
ProCAncer-I at the first EIT Health Morning Talks in Bosnia and Herzegovina
Harnessing Big Data for the Future of Healthcare: Innovative Solutions with EUCAIM, ProCAncer-I, and European Health Data Spaces
ProCAncer-I at the EMUC24 in Lisbon
The progress of major trials, the advent of artificial intelligence (AI), and interdisciplinary best practices were discussed at the 16th European Multidisciplinary Congress on Urological Cancers (EMUC24). The congress took place from the 7th to 10th of November 2024...
Third Dissemination Event of the ProCAncer-I Project in Athens
ProCAncer-I organised the 3rd Dissemination Event of the project at the 21st IEEE International Symposium on Biomedical Imaging, held in Athens, Greece, May 27-30, 2024. During the symposium, ProCAncer-I organised the Workshop “Integrating imaging Data and AI models...
AI in PCa imaging : The current status and future perspectives
Ιn recent years, magnetic resonance imaging (MRI) has transformed the prostate cancer (PCa) diagnostic pathway, based on the evidence of multiple high-level evidence studies (refs 4M, MRI first, and PROMIS). Taken together, the evidence indicates that prostate MRI...
Open Call To Include New Beneficiaries Into The EUCAIM Consortium
The EUCAIM project is launching an open call for new beneficiaries to join the consortium. The objective of the EUCAIM open call is to: i) onboard new cancer image data holders, increasing the geographic dimensions, data modalities or cancer targets, and ii) include...
Third Dissemination Event of the ProCAncer-I Project in Athens
ProCAncer-I will be organising the 3rd Dissemination Event at the 21st IEEE International Symposium on Biomedical Imaging, which will be held in Athens, Greece, May 27-30, 2024. ProCAncer-I will organise the Workshop “Integrating imaging Data and AI models for...
ProCAncer-I at the ECR 2024 in Vienna
A great congress once more! Artificial Intelligence (AI) took the spotlight at the European Radiology Congress (ECR) held at the Austria Center Vienna from February 28 to March 3. Under the theme of 'Next Generation Radiology,' cutting-edge technologies were...
Gold medal from the European Society of Radiology to Prof. Dr. Deniz Akata
Hacettepe University Department of Radiology Faculty Member Prof. Dr. Deniz Akata was awarded the ESR Gold Medal by the European Society of Radiology for her contributions to the field of radiology and European radiology. Prof. Dr. Deniz Akata is the first Turkish...
